Finance

Lists
Why is FLGT up 27,22%?
Dive Deeper
FLGT:NASDAQ
Fulgent Genetics Inc
USD 23,74
+27,22%
(+5,08) 1D
USD 23,74
0,00% (0,00)
After hours
Closed: 6 Nov., 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FLGT...
Open
USD 20,47
High
USD 23,85
Low
USD 19,64
Mkt. cap
653,21 m
Avg. vol.
282,83 k
Volume
1,10 m
52-wk high
USD 31,04
52-wk low
USD 13,46
EPS
-USD 2,83
Beta
1,00
Shares outstanding
27,52 m
No. of employees
1 k
Open
USD 20,47
High
USD 23,85
Low
USD 19,64
Mkt. cap
653,21 m
Avg. vol.
282,83 k
Volume
1,10 m
52-wk high
USD 31,04
52-wk low
USD 13,46
EPS
-USD 2,83
Beta
1,00
Shares outstanding
27,52 m
No. of employees
1 k
News stories
From web sources and news partners
About Fulgent Genetics Inc
CEOMing Hsieh
Employees1,32 k
Founded2011
HeadquartersTemple City, Kalifornië, Verenigde State van Amerika
SectorHealth Care
IndustryHealth care provider
Websitefulgentgenetics.com
Analyst ratings
Based on 1 analyst giving stock ratings to FLGT in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for FLGT in the last 3 months
Highest
Current USD 23,74
USD 19,00 (-19,97%)
Average
USD 19,00 (-19,97%)
Lowest
USD 19,00 (-19,97%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Westenberg
Piper Sandler
Hold
Maintained
USD 19,00
-20%
11/06/2026
Lu Li
UBS
Buy
Maintained
USD 22,00
-7,3%
03/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
84,07 m
83,34 m
71,14 m
85,39 m
Cost of goods sold
48,56 m
50,75 m
49,65 m
59,71 m
Cost of revenue
48,56 m
50,75 m
49,65 m
59,71 m
Research and development expenses
13,86 m
14,17 m
14,18 m
14,55 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34,98 m
50,70 m
37,30 m
42,12 m
Operating expense
50,86 m
66,90 m
53,51 m
59,28 m
Total operating expenses
99,42 m
117,65 m
103,16 m
118,99 m
Operating income
-15,35 m
-34,31 m
-32,02 m
-33,60 m
Other non operating income
-5,00 k
44,00 k
10,00 k
38,00 k
EBT including unusual items
-7,51 m
-29,27 m
-25,98 m
-29,69 m
EBT excluding unusual items
-7,51 m
-27,35 m
-23,38 m
-27,22 m
Income tax expense
-683,00 k
-5,62 m
-704,00 k
29,00 k
Effective tax rate
9,10%
19,21%
2,71%
-0,10%
Other operating expenses
-
-
-
-
Net income
-6,61 m
-23,42 m
-24,83 m
-29,53 m
Net profit margin
-7,86%
-28,10%
-34,90%
-34,58%
Earnings per share
0,14
0,16
-0,36
-0,58
Interest and investment income
7,87 m
6,94 m
8,65 m
6,40 m
Interest expense
-28,00 k
-16,00 k
-17,00 k
-59,00 k
Net interest expenses
7,85 m
6,92 m
8,63 m
6,34 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,31 m
-28,20 m
-26,02 m
-25,92 m
Gain or loss from assets sale
-1,00 k
-
-9,00 k
19,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme